Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Atzeni

Showing results (241-250 of 395) with videos related to

Pageof 40
Sort By:
Clinical and Experimental Rheumatology|January 18, 2019
Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomesRossella Talotta, Vincenzo Mercurio, Sara Bongiovanni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 17, 2017
Co-Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia: Results From a UK National RegisterGary J Macfarlane, Maxwell S Barnish, Ejaz Pathan, et al.
Expert Review of Clinical Immunology|September 13, 2019
Medical cannabis and cannabinoids in rheumatology: where are we now?Piercarlo Sarzi-Puttini, Alberto Batticciotto, Fabiola Atzeni, et al.
Current Pain and Headache Reports|July 23, 2024
Pharmacological Treatment of Fibromyalgia Syndrome: A Practice-Based ReviewValeria Giorgi, Piercarlo Sarzi-Puttini, Greta Pellegrino, et al.
Clinical and Experimental Rheumatology|December 2, 2014
Position paper of Italian rheumatologists on the use of biosimilar drugsFabiola Atzeni, Marco Sebastiani, Cristian Ricci, et al.
Clinical and Experimental Rheumatology|March 19, 2015
A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary dataPaolo Leombruni, Marco Miniotti, Fabrizio Colonna, et al.
Rheumatology (Oxford, England)|October 6, 2018
The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus ConferenceFabrizio Conti, Fabiola Atzeni, Laura Massaro, et al.
Recenti Progressi in Medicina|September 24, 2009
[Anti-PR3 positive inflammatory bowel disease. Description of a case]Caterina Defendenti, Simona Bollani, Maria Francesca Spina, et al.
Autoimmunity Reviews|May 31, 2015
Measuring psoriatic disease in clinical practice. An expert opinion position paperEnnio Lubrano, Fabrizio Cantini, Antonio Costanzo, et al.
Rheumatology (Oxford, England)|January 8, 2023
Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stagesJavier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, et al.
Pageof 40

Showing results (241-250 of 395) with videos related to

Sort By:
Pageof 40
Clinical and Experimental Rheumatology|January 18, 2019
Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomesRossella Talotta, Vincenzo Mercurio, Sara Bongiovanni, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 17, 2017
Co-Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia: Results From a UK National RegisterGary J Macfarlane, Maxwell S Barnish, Ejaz Pathan, et al.
Expert Review of Clinical Immunology|September 13, 2019
Medical cannabis and cannabinoids in rheumatology: where are we now?Piercarlo Sarzi-Puttini, Alberto Batticciotto, Fabiola Atzeni, et al.
Current Pain and Headache Reports|July 23, 2024
Pharmacological Treatment of Fibromyalgia Syndrome: A Practice-Based ReviewValeria Giorgi, Piercarlo Sarzi-Puttini, Greta Pellegrino, et al.
Clinical and Experimental Rheumatology|December 2, 2014
Position paper of Italian rheumatologists on the use of biosimilar drugsFabiola Atzeni, Marco Sebastiani, Cristian Ricci, et al.
Clinical and Experimental Rheumatology|March 19, 2015
A randomised controlled trial comparing duloxetine and acetyl L-carnitine in fibromyalgic patients: preliminary dataPaolo Leombruni, Marco Miniotti, Fabrizio Colonna, et al.
Rheumatology (Oxford, England)|October 6, 2018
The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus ConferenceFabrizio Conti, Fabiola Atzeni, Laura Massaro, et al.
Recenti Progressi in Medicina|September 24, 2009
[Anti-PR3 positive inflammatory bowel disease. Description of a case]Caterina Defendenti, Simona Bollani, Maria Francesca Spina, et al.
Autoimmunity Reviews|May 31, 2015
Measuring psoriatic disease in clinical practice. An expert opinion position paperEnnio Lubrano, Fabrizio Cantini, Antonio Costanzo, et al.
Rheumatology (Oxford, England)|January 8, 2023
Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stagesJavier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, et al.
Pageof 40